%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/14656566.2020.1806237
en
Fixed-dose combination therapy for Parkinson’s disease with a spotlight on entacapone in the past 20 years: a reduced pill burden and a simplified dosing regime
András Salamon
Dénes Zádori
László Szpisjak
Péter Klivényi
László Vécsei
Taylor & Francis
Expert Opinion on Pharmacotherapy, 2020. doi:10.1080/14656566.2020.1806237
Adherence
combination
entacapone
fixed-dose
non-motor symptoms
Parkinson’s disease
UPDRS
Journal
Expert Opinion on Pharmacotherapy
© 2020 Informa UK Limited, trading as Taylor & Francis Group
1465-6566
1744-7666
00
00
1
14
10.1080/14656566.2020.1806237
https://doi.org/10.1080/14656566.2020.1806237
VoR
2020-08-14T04:56:44+05:30
Arbortext Advanced Print Publisher 11.0.3433/W Unicode
2020-08-19T06:59:42-07:00
2020-08-19T06:59:42-07:00
Adherence; combination; entacapone; fixed-dose; non-motor symptoms; Parkinson’s disease; UPDRS
iText 4.2.0 by 1T3XT
uuid:3005e5e1-5743-4292-8e7a-03be792cd5ab
uuid:ed00d1c3-d55b-4058-a574-2faf4950e066
2020-08-18truewww.tandfonline.com10.1080/14656566.2020.1806237www.tandfonline.comtrue2020-08-1810.1080/14656566.2020.1806237
endstream
endobj
4 0 obj
<>stream
xZMo4
W"
n!ȩmC"HFu1H_(jzrſЭ ?$ns-dߟ^ޞǸ퇝gZcXjlowֿXzml>onݰ-Ej+9XjOrvwWl/0636}uvq_Èb)7%Wji~䃉o',~eѿ^TvcQD@jbVqCUɁɗzƪPbJuH) ,.'!&sx&ƛsiKx<,-,/GM[eL~`ݒ\.p:FM94_N/D5' ok騿ZfNG,A2ܳ+Ftotmaq= K%)/[Ks(s!!W;G)C6) =eаL2]Zvk\~@P0 C|xCFܦ1r"&r+wX9=dJ(x@$({8Y|lJ
0 &+aQC)[仰Qە@ջ8Ed*=ӄ(4*?
c\J
p]cWy%028KbaR˚B#Lf-;HsZIӲ2SV0%f/v`էjnCףv6 d2P}qyɃ&=q$=faܕR|`ysa7a< {ƾ>glF8ZRYSLP%s2D5K]4X*(.'#c(}UKV⥾1.`dÍ<ubJEfh W$p!g 38kWgX""p 1JlTzʃ)gf@!cyoYE^GjigFDSM?